These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31478310)

  • 1. Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing.
    Reuter CM; Kohler JN; Bonner D; Zastrow D; Fernandez L; Dries A; Marwaha S; Davidson J; Brokamp E; Herzog M; Hong J; Macnamara E; Rosenfeld JA; Schoch K; Spillmann R; ; Loscalzo J; Krier J; Stoler J; Sweetser D; Palmer CGS; Phillips JA; Shashi V; Adams DA; Yang Y; Ashley EA; Fisher PG; Mulvihill JJ; Bernstein JA; Wheeler MT
    J Genet Couns; 2019 Dec; 28(6):1107-1118. PubMed ID: 31478310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Whole exome sequencing and whole genome sequencing in undiagnosed disease: of value for certain patient populations].
    Linthorst GE; Hollak CEM
    Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Has the Undiagnosed Diseases Network Taught Us About the Clinical Applications of Genomic Testing?
    Murdock DR; Rosenfeld JA; Lee B
    Annu Rev Med; 2022 Jan; 73():575-585. PubMed ID: 35084988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care context.
    van Slobbe M; van Haeringen A; Vissers LELM; Bijlsma EK; Rutten JW; Suerink M; Nibbeling EAR; Ruivenkamp CAL; Koene S
    Eur J Pediatr; 2024 Jan; 183(1):345-355. PubMed ID: 37889289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of whole-exome sequencing results in neurogenetic diseases.
    Balasar Ö; Başdemirci M
    J Hum Genet; 2023 Dec; 68(12):797-804. PubMed ID: 37524782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders.
    Dillon OJ; Lunke S; Stark Z; Yeung A; Thorne N; ; Gaff C; White SM; Tan TY
    Eur J Hum Genet; 2018 May; 26(5):644-651. PubMed ID: 29453417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of exome sequencing in detecting rare and undiagnosed diseases.
    Burdick KJ; Cogan JD; Rives LC; Robertson AK; Koziura ME; Brokamp E; Duncan L; Hannig V; Pfotenhauer J; Vanzo R; Paul MS; Bican A; Morgan T; Duis J; Newman JH; Hamid R; Phillips JA;
    Am J Med Genet A; 2020 Jun; 182(6):1400-1406. PubMed ID: 32190976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of whole-exome sequencing in Chinese pediatric-onset neuromuscular patients.
    Tsang MHY; Chiu ATG; Kwong BMH; Liang R; Yu MHC; Yeung KS; Ho WHL; Mak CCY; Leung GKC; Pei SLC; Fung JLF; Wong VCN; Muntoni F; Chung BHY; Chan SHS
    Mol Genet Genomic Med; 2020 May; 8(5):e1205. PubMed ID: 32154989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort study.
    Shickh S; Gutierrez Salazar M; Zakoor KR; Lázaro C; Gu J; Goltz J; Kleinman D; Noor A; Khalouei S; Mighton C; Reble E; Kodida R; Bombard Y; DiTroia S; Baxter S; Watkins N; Care M; Adler A; Horsburgh S; Morar O; Murphy J; Nevay DL; Szybowska M; Aronson M; Panchal S; Godoy R; Holter S; Randall Armel S; Semotiuk K; Elser C; Kim RH; Chitayat D; So J; Faghfoury H; Silver J; Morel CF; Lerner-Ellis J
    J Med Genet; 2021 Apr; 58(4):275-283. PubMed ID: 32581083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach.
    Córdoba M; Rodriguez-Quiroga SA; Vega PA; Salinas V; Perez-Maturo J; Amartino H; Vásquez-Dusefante C; Medina N; González-Morón D; Kauffman MA
    PLoS One; 2018; 13(2):e0191228. PubMed ID: 29389947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positioning whole exome sequencing in the diagnostic pathway for rare disease to optimise utility: a protocol for an observational cohort study and an economic evaluation.
    Hayeems RZ; Bernier F; Boycott KM; Hartley T; Michaels-Igbokwe C; Marshall DA
    BMJ Open; 2022 Oct; 12(10):e061468. PubMed ID: 36216418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Singapore Undiagnosed Disease Program: Genomic Analysis aids Diagnosis and Clinical Management.
    Bhatia NS; Lim JY; Bonnard C; Kuan JL; Brett M; Wei H; Cham B; Chin H; Bosso-Lefevre C; Dharuman P; Escande-Beillard N; Devasia AG; Goh CYJ; Kam S; Liew WK; Liew WK; Lin G; Jain K; Ng AY; Subramanian D; Xie M; Tan YM; Tawari NR; Tiang Z; Ting TW; Tohari S; Tong CK; Lezhava A; Ng SB; Law HY; Venkatesh B; Tomar S; Sethi R; Tan G; Shanmugasundaram A; Goh DL; Lai PS; Lai A; Tan ES; Ng I; Reversades B; Tan EC; Foo R; Jamuar SS;
    Arch Dis Child; 2021 Jan; 106(1):31-37. PubMed ID: 32819910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced resource utilization with early use of next-generation sequencing in rare genetic diseases in an Asian cohort.
    Nazeha N; Koh AL; Kam S; Lim JY; Goh DLM; Jamuar SS; Graves N
    Am J Med Genet A; 2022 Dec; 188(12):3482-3491. PubMed ID: 36156406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS).
    Trosman JR; Weldon CB; Slavotinek A; Norton ME; Douglas MP; Phillips KA
    Genet Med; 2020 Feb; 22(2):283-291. PubMed ID: 31501586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine Learning of Patient Characteristics to Predict Admission Outcomes in the Undiagnosed Diseases Network.
    Amiri H; Kohane IS;
    JAMA Netw Open; 2021 Feb; 4(2):e2036220. PubMed ID: 33630084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of Whole Exome Sequencing for Diagnostic Odyssey Cases of an Individualized Medicine Clinic: The Mayo Clinic Experience.
    Lazaridis KN; Schahl KA; Cousin MA; Babovic-Vuksanovic D; Riegert-Johnson DL; Gavrilova RH; McAllister TM; Lindor NM; Abraham RS; Ackerman MJ; Pichurin PN; Deyle DR; Gavrilov DK; Hand JL; Klee EW; Stephens MC; Wick MJ; Atkinson EJ; Linden DR; Ferber MJ; Wieben ED; Farrugia G;
    Mayo Clin Proc; 2016 Mar; 91(3):297-307. PubMed ID: 26944241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missed diagnoses: Clinically relevant lessons learned through medical mysteries solved by the Undiagnosed Diseases Network.
    Cope H; Spillmann R; Rosenfeld JA; Brokamp E; Signer R; Schoch K; Glanton E; Sullivan JA; Macnamara E; Lincoln S; Golden-Grant K; ; Orengo JP; Clark G; Burrage LC; Posey JE; Punetha J; Robertson A; Cogan J; Phillips JA; Martinez-Agosto J; Shashi V
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1397. PubMed ID: 32730690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.
    Tan TY; Dillon OJ; Stark Z; Schofield D; Alam K; Shrestha R; Chong B; Phelan D; Brett GR; Creed E; Jarmolowicz A; Yap P; Walsh M; Downie L; Amor DJ; Savarirayan R; McGillivray G; Yeung A; Peters H; Robertson SJ; Robinson AJ; Macciocca I; Sadedin S; Bell K; Oshlack A; Georgeson P; Thorne N; Gaff C; White SM
    JAMA Pediatr; 2017 Sep; 171(9):855-862. PubMed ID: 28759686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-Exome Sequencing Enables a Precision Medicine Approach for Kidney Transplant Recipients.
    Mann N; Braun DA; Amann K; Tan W; Shril S; Connaughton DM; Nakayama M; Schneider R; Kitzler TM; van der Ven AT; Chen J; Ityel H; Vivante A; Majmundar AJ; Daga A; Warejko JK; Lovric S; Ashraf S; Jobst-Schwan T; Widmeier E; Hugo H; Mane SM; Spaneas L; Somers MJG; Ferguson MA; Traum AZ; Stein DR; Baum MA; Daouk GH; Lifton RP; Manzi S; Vakili K; Kim HB; Rodig NM; Hildebrandt F
    J Am Soc Nephrol; 2019 Feb; 30(2):201-215. PubMed ID: 30655312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel.
    Tal-Ben Ishay R; Shil A; Solomon S; Sadigurschi N; Abu-Kaf H; Meiri G; Flusser H; Michaelovski A; Dinstein I; Golan H; Davidovitch N; Menashe I
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.